Campbell Michael Gerard 4
4 · Comera Life Sciences Holdings, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
Campbell Michael Gerard
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2022-06-15+450,000→ 450,000 totalExercise: $3.72Exp: 2032-06-15→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest over four (4) years, with twenty-five percent (25%) of the shares of Common Stock underlying the option vesting on June 15, 2023 and the remainder vesting in equal monthly installments thereafter.